Moleculin Biotech Inc. (MBRX)
NASDAQ: MBRX
· Real-Time Price · USD
0.67
0.02 (3.43%)
At close: Aug 15, 2025, 3:59 PM
0.69
2.85%
After-hours: Aug 15, 2025, 07:43 PM EDT
Moleculin Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.55M | -23.23M | -21.76M | -30.15M | -25.17M | -26.82M | -29.77M | -26.27M | -29.27M | -30.07M | -29.02M | -25.08M | -20.85M | -18.32M | -15.89M | -15.71M | -14.72M | -20.59M |
Depreciation & Amortization | 122K | 125K | 126K | 130K | 129K | 129K | 127K | 124K | 125K | 128K | 130K | 132K | 142K | 152K | 164K | 176K | 190K | 198K |
Stock-Based Compensation | 1.68M | 1.72M | 1.73M | 1.78M | 1.92M | 1.98M | 1.98M | 2.04M | 2.25M | 2.25M | 2.27M | 2.3M | 2.58M | 2.5M | 2.37M | 2.23M | 1.71M | 1.69M |
Other Working Capital | 2.41M | 1.26M | 699K | 1.86M | 708K | 6K | 1.22M | -930K | -264K | 1.58M | 1.61M | 1.35M | 1.89M | 479K | 803K | 618K | 577K | 903K |
Other Non-Cash Items | 1.12M | -2.19M | -4.18M | 1.72M | -1.85M | -159K | 2.03M | 683K | 273K | 273K | -640K | -491K | -89K | -87K | 96K | 97K | 99K | 99K |
Deferred Income Tax | n/a | n/a | n/a | -59K | -60K | -96K | -96K | -37K | -36K | n/a | n/a | -2.3M | -3.98M | -5.15M | -6.73M | -5.28M | -6.34M | -72K |
Change in Working Capital | 2.28M | 1.86M | 231K | 2.4M | -595K | 171K | 1.62M | -2.49M | 688K | -823K | 224K | 1.41M | 1.45M | 775K | 1.04M | 665K | 164K | 1.63M |
Operating Cash Flow | -21.34M | -21.71M | -23.86M | -24.19M | -25.62M | -24.8M | -24.1M | -25.95M | -25.98M | -28.85M | -27.64M | -24.64M | -21.35M | -20.13M | -18.95M | -17.82M | -18.9M | -17.05M |
Capital Expenditures | n/a | -13K | -13K | -94K | -122K | -124K | -124K | -110K | -82K | -128K | -134K | -86K | -86K | -25K | -19K | -16K | -356K | -374K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | 2K |
Investing Cash Flow | n/a | -13K | -13K | -94K | -122K | -124K | -124K | -110K | -82K | -128K | -134K | -86K | -86K | -25K | -19K | -14K | -354K | -372K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -25 | -25 | -25 | -4.03K | -4K | -4K | -4K | -11 | -23 | -23 | -23 | -36 | -24 | -24 | -24 | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 10.09M | 4.64M | 4.64M | 484.02K | 485.02K | 489K | 489K | -33K | -44K | -35K | -35K | -22K | -35K | -23K | 40K | 39K | 46K | 51K |
Financial Cash Flow | 18.08M | 12.63M | 4.63M | 9.1M | 4.44M | 4.46M | 4.46M | -15.81K | -22.81K | -34.86K | -35K | -24K | -37K | -25K | 74.72M | 80.21M | 81.99M | 92.01M |
Net Cash Flow | -3.29M | -9.11M | -19.27M | -15.17M | -21.33M | -20.44M | -19.59M | -25.81M | -25.83M | -28.84M | -27.76M | -24.79M | -21.51M | -20.19M | 55.73M | 62.38M | 62.77M | 74.64M |
Free Cash Flow | -21.34M | -21.72M | -23.88M | -24.28M | -25.75M | -24.93M | -24.23M | -26.06M | -26.06M | -28.98M | -27.77M | -24.73M | -21.44M | -20.16M | -18.97M | -17.83M | -19.26M | -17.43M |